ES8601995A1 - Un procedimiento para preparar s-triazolo(3, 4-a)ftalazinas - Google Patents
Un procedimiento para preparar s-triazolo(3, 4-a)ftalazinasInfo
- Publication number
- ES8601995A1 ES8601995A1 ES531458A ES531458A ES8601995A1 ES 8601995 A1 ES8601995 A1 ES 8601995A1 ES 531458 A ES531458 A ES 531458A ES 531458 A ES531458 A ES 531458A ES 8601995 A1 ES8601995 A1 ES 8601995A1
- Authority
- ES
- Spain
- Prior art keywords
- substd
- opt
- alkyl
- alkoxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 6-substituted-s-triazolo(3,4-a)phthalazine Chemical class 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 18
- 125000003545 alkoxy group Chemical group 0.000 abstract 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 14
- 229910052736 halogen Inorganic materials 0.000 abstract 11
- 150000002367 halogens Chemical class 0.000 abstract 11
- 125000000623 heterocyclic group Chemical group 0.000 abstract 8
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 7
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 6
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 6
- 125000003282 alkyl amino group Chemical group 0.000 abstract 5
- 125000004691 alkyl thio carbonyl group Chemical group 0.000 abstract 5
- 125000004414 alkyl thio group Chemical group 0.000 abstract 5
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 4
- 125000005842 heteroatom Chemical group 0.000 abstract 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- JVJPJKLSGUJUJK-UHFFFAOYSA-N [1,2,4]triazolo[3,4-a]phthalazine Chemical compound C1=CC=C2C=NN3C=NN=C3C2=C1 JVJPJKLSGUJUJK-UHFFFAOYSA-N 0.000 abstract 3
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 3
- 125000004685 alkoxythiocarbonyl group Chemical group 0.000 abstract 3
- 229910052794 bromium Inorganic materials 0.000 abstract 3
- 229910052801 chlorine Inorganic materials 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 229910052731 fluorine Inorganic materials 0.000 abstract 3
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 229910052740 iodine Inorganic materials 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 abstract 2
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 abstract 1
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8201273 | 1982-01-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES531458A0 ES531458A0 (es) | 1985-11-01 |
| ES8601995A1 true ES8601995A1 (es) | 1985-11-01 |
Family
ID=10527683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES531458A Expired ES8601995A1 (es) | 1982-01-18 | 1984-04-10 | Un procedimiento para preparar s-triazolo(3, 4-a)ftalazinas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4788186A (enEXAMPLES) |
| EP (1) | EP0085840B1 (enEXAMPLES) |
| JP (1) | JPS58124786A (enEXAMPLES) |
| KR (1) | KR890000184B1 (enEXAMPLES) |
| AT (1) | ATE22562T1 (enEXAMPLES) |
| AU (1) | AU564026B2 (enEXAMPLES) |
| CA (1) | CA1214168A (enEXAMPLES) |
| DE (1) | DE3366494D1 (enEXAMPLES) |
| DK (1) | DK163145C (enEXAMPLES) |
| ES (1) | ES8601995A1 (enEXAMPLES) |
| FI (1) | FI81350C (enEXAMPLES) |
| GR (1) | GR78442B (enEXAMPLES) |
| HU (1) | HU193033B (enEXAMPLES) |
| IE (1) | IE55032B1 (enEXAMPLES) |
| IL (1) | IL67697A (enEXAMPLES) |
| NO (1) | NO161674C (enEXAMPLES) |
| NZ (1) | NZ203021A (enEXAMPLES) |
| PH (1) | PH21834A (enEXAMPLES) |
| PT (1) | PT76107A (enEXAMPLES) |
| ZA (1) | ZA83224B (enEXAMPLES) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1194310B (it) * | 1983-07-12 | 1988-09-14 | Lepetit Spa | Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti |
| ATE236904T1 (de) * | 1996-07-25 | 2003-04-15 | Merck Sharp & Dohme | Substituierte triazolo-pyridazin-derivate als liganden von gaba-rezeptoren |
| US6465462B1 (en) | 1996-07-25 | 2002-10-15 | Merck Sharp & Dohme Ltd. | Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAα5 receptor subtype |
| WO1998050385A1 (en) * | 1997-05-08 | 1998-11-12 | Merck Sharp & Dohme Limited | SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS |
| GB9715977D0 (en) | 1997-07-29 | 1997-10-01 | Merck Sharp & Dohme | Therapeutic agents |
| ES2137113B1 (es) * | 1997-07-29 | 2000-09-16 | Almirall Prodesfarma Sa | Nuevos derivados de triazolo-piridazinas heterociclicos. |
| GB9723999D0 (en) | 1997-11-13 | 1998-01-14 | Merck Sharp & Dohme | Therapeutic use |
| GB9726699D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
| GB9726701D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
| AU1041599A (en) * | 1997-11-13 | 1999-06-07 | Jose Luis Castro Pineiro | Therapeutic uses of triazolo-pyridazine derivatives |
| GB9726702D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
| US6110915A (en) * | 1997-12-18 | 2000-08-29 | Merck & Co., Inc. | Antiemetic use of triazolo-pyridazine derivatives |
| JP2002509150A (ja) * | 1998-01-14 | 2002-03-26 | メルク シャープ エンド ドーム リミテッド | Ｇａｂａ受容体のリガンドとしてのトリアゾロピリダジン誘導体 |
| GB9801202D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801208D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801234D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| MXPA00007135A (es) | 1998-01-21 | 2002-11-07 | Merck Sharp & Dohme | Derivados de triazolo-piridazina como ligandos para receptores gaba. |
| GB9801210D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801397D0 (en) | 1998-01-22 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801538D0 (en) | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
| US6448249B1 (en) | 1998-02-25 | 2002-09-10 | Merck Sharp & Dohme Ltd. | Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligands |
| PL341975A1 (en) * | 1998-02-25 | 2001-05-07 | Merck Sharp & Dohme | Substituted 1,2,4-triazole[3,4-a]phtalazine |
| GB9824897D0 (en) | 1998-11-12 | 1999-01-06 | Merck Sharp & Dohme | Therapeutic compounds |
| JP2002529468A (ja) | 1998-11-12 | 2002-09-10 | メルク エンド カムパニー インコーポレーテッド | ＧＡＢＡ−Ａα−５逆活性薬の治療性多形およびそのパモエート組成物 |
| GB9929569D0 (en) * | 1999-12-14 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
| GB0028583D0 (en) | 2000-11-23 | 2001-01-10 | Merck Sharp & Dohme | Therapeutic compounds |
| WO2002083140A1 (en) * | 2001-04-10 | 2002-10-24 | Merck & Co., Inc. | Inhibitors of akt activity |
| EP1379250A2 (en) * | 2001-04-10 | 2004-01-14 | Merck & Co., Inc. | A method of treating cancer |
| AU2003226301A1 (en) * | 2002-04-08 | 2003-10-20 | Merck And Co., Inc. | Method of treating cancer |
| US20050054647A1 (en) * | 2002-12-27 | 2005-03-10 | Detlev Schuppan | New pharmaceutical combination |
| KR101368093B1 (ko) * | 2004-09-02 | 2014-03-14 | 다케다 게엠베하 | 트리아졸로프탈라진 |
| AU2006204454B2 (en) | 2005-01-05 | 2011-11-10 | Takeda Gmbh | Triazolophthalazines as PDE2-inhibitors |
| ES2397082T3 (es) | 2005-01-05 | 2013-03-04 | Nycomed Gmbh | Triazoloftalazinas como inhibidores de PDE2 |
| PH12012501361A1 (en) | 2009-12-31 | 2012-10-22 | Centro Nac De Investigaciones Oncologicas Cnio | Tricyclic compounds for use as kinase inhibitors |
| CN103694244B (zh) * | 2014-01-09 | 2016-03-30 | 郑州大学 | 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途 |
| CN104016986B (zh) * | 2014-03-13 | 2016-02-03 | 郑州大学 | 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途 |
| EP4279074A1 (en) * | 2022-05-19 | 2023-11-22 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Azolo compounds for treatment of fibrotic diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB629177A (en) * | 1945-12-21 | 1949-09-14 | Ciba Ltd | Manufacture of new hydrazine compounds and derivatives thereof |
| US2484029A (en) * | 1945-12-21 | 1949-10-11 | Ciba Pharm Prod Inc | Hydrazine derivatives of pyridazine compounds |
| JPS5132598A (en) * | 1974-09-13 | 1976-03-19 | Eisai Co Ltd | Toriazoro * 3 44 ee * futarajinjudotai no goseiho |
| JPS603080B2 (ja) * | 1976-08-10 | 1985-01-25 | 三菱化学株式会社 | Ｓ―トリアゾロ〔３，４ ―α〕〔５，６，７，８〕テトラヒドロ フタラジン類 |
| GR70309B (enEXAMPLES) * | 1979-10-29 | 1982-09-08 | Dow Chemical Co |
-
1983
- 1983-01-12 FI FI830100A patent/FI81350C/fi not_active IP Right Cessation
- 1983-01-12 PH PH28380A patent/PH21834A/en unknown
- 1983-01-13 ZA ZA83224A patent/ZA83224B/xx unknown
- 1983-01-13 DE DE8383100232T patent/DE3366494D1/de not_active Expired
- 1983-01-13 EP EP83100232A patent/EP0085840B1/en not_active Expired
- 1983-01-13 CA CA000419398A patent/CA1214168A/en not_active Expired
- 1983-01-13 AT AT83100232T patent/ATE22562T1/de not_active IP Right Cessation
- 1983-01-13 NZ NZ203021A patent/NZ203021A/en unknown
- 1983-01-13 GR GR70257A patent/GR78442B/el unknown
- 1983-01-14 NO NO830110A patent/NO161674C/no unknown
- 1983-01-17 IL IL67697A patent/IL67697A/xx unknown
- 1983-01-17 HU HU83141A patent/HU193033B/hu not_active IP Right Cessation
- 1983-01-17 IE IE82/83A patent/IE55032B1/en not_active IP Right Cessation
- 1983-01-18 KR KR1019830000174A patent/KR890000184B1/ko not_active Expired
- 1983-01-18 AU AU10550/83A patent/AU564026B2/en not_active Ceased
- 1983-01-18 JP JP58005413A patent/JPS58124786A/ja active Granted
- 1983-01-18 DK DK017983A patent/DK163145C/da not_active IP Right Cessation
- 1983-01-18 PT PT76107A patent/PT76107A/pt unknown
-
1984
- 1984-04-10 ES ES531458A patent/ES8601995A1/es not_active Expired
-
1987
- 1987-10-20 US US07/112,015 patent/US4788186A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO830110L (no) | 1983-07-19 |
| FI830100L (fi) | 1983-07-19 |
| ATE22562T1 (de) | 1986-10-15 |
| PH21834A (en) | 1988-03-17 |
| AU564026B2 (en) | 1987-07-30 |
| JPS58124786A (ja) | 1983-07-25 |
| US4788186A (en) | 1988-11-29 |
| KR890000184B1 (ko) | 1989-03-09 |
| CA1214168A (en) | 1986-11-18 |
| GR78442B (enEXAMPLES) | 1984-09-27 |
| JPH048428B2 (enEXAMPLES) | 1992-02-17 |
| IE830082L (en) | 1983-07-18 |
| FI81350B (fi) | 1990-06-29 |
| DE3366494D1 (de) | 1986-11-06 |
| PT76107A (en) | 1983-02-01 |
| ES531458A0 (es) | 1985-11-01 |
| EP0085840B1 (en) | 1986-10-01 |
| NO161674B (no) | 1989-06-05 |
| IL67697A (en) | 1990-02-09 |
| IL67697A0 (en) | 1983-05-15 |
| DK163145C (da) | 1992-06-22 |
| EP0085840A1 (en) | 1983-08-17 |
| DK17983A (da) | 1983-07-19 |
| IE55032B1 (en) | 1990-05-09 |
| AU1055083A (en) | 1983-07-28 |
| ZA83224B (en) | 1983-10-26 |
| NO161674C (no) | 1989-09-13 |
| NZ203021A (en) | 1986-05-09 |
| KR840003254A (ko) | 1984-08-20 |
| FI830100A0 (fi) | 1983-01-12 |
| HU193033B (en) | 1987-08-28 |
| FI81350C (fi) | 1990-10-10 |
| DK163145B (da) | 1992-01-27 |
| DK17983D0 (da) | 1983-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8601995A1 (es) | Un procedimiento para preparar s-triazolo(3, 4-a)ftalazinas | |
| NO305365B1 (no) | Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter | |
| EG20267A (en) | Process for preparing of substituted pyrimidine compounds and their use as pesticides | |
| DE69835434D1 (de) | Verwendung von colchinolderivate zur gefässschädigung | |
| ES8603879A1 (es) | Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil) oxialquilamidas | |
| BG106286A (en) | Respiratory syncytial virus replication inhibitors | |
| EP0726903A1 (en) | INHIBITORS OF MATRIX METALLOPROTEASES | |
| MY119254A (en) | 1, 3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives | |
| ES8602707A1 (es) | Procedimiento para preparar 2-fenil-hexahidro-1,2,4-triazin-3,5-dionas substituidas | |
| ES8607920A1 (es) | Procedimiento para preparar nuevas bis-(4-aminofenil)-sulfo-nas substituidas | |
| FR2230366A1 (en) | Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity | |
| ES8500943A1 (es) | Un procedimiento para preparar 1-triazolo(3,4-a)ftalazinas | |
| BG104933A (en) | Water soluble azoles and broad-spectrum antifungals | |
| ES8602649A1 (es) | Procedimiento para preparar 4-hidroximetil-pirrolidinonas substituidas en posicion 1 | |
| NO306296B1 (no) | Substituerte kinolinderivater og deres anvendelse samt legemidler inneholdende derilvatene | |
| ES8604894A1 (es) | Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas | |
| BE815405A (en) | Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity | |
| FR2135740A5 (en) | Herbicidal s-aryl arylamides | |
| FR2164520A2 (en) | 2-(n-heterocyclic amino)thiazolin-4-ones - with respiratory analeptic activity | |
| GB8716337D0 (en) | Antipsychotic compositions | |
| IT1093255B (it) | Derivati fenossialcanolaminici | |
| MY107787A (en) | Therapeutic agents | |
| FR2305185A2 (fr) | Nouveaux derives de la cephalospo | |
| NL7105652A (en) | Herbicidal s-aryl arylamides | |
| AR011251A1 (es) | Metodo de utilizacion de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de neoplasias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970303 |